NBC
IART icon

Neuberger Berman Canada’s Integra LifeSciences IART Stock Holding History

Neuberger Berman Canada’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,472
Closed -$843K – 342
2017
Q2 		$843K Sell
15,472
-11,163
-42% -$533K 0.16% 195
2017
Q1 		$1.12M Buy
26,635
+14,231
+115% +$608K 0.22% 117
2016
Q4 		$266K Buy
+12,404
New +$504K 0.07% 190

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Neuberger Berman Canada's IART Position: Q3 2017 in Review

Neuberger Berman Canada sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 15,472 shares — an estimated $843K sold.

Neuberger Berman Canada first reported a position in IART in Q4 2016 and held it in 3 quarters. The position peaked at $1.12M in Q1 2017. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • Neuberger Berman Canada reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • Neuberger Berman Canada sold 15,472 Integra LifeSciences shares in Q3 2017, an estimated $843K.
  • Neuberger Berman Canada first reported a position in Integra LifeSciences in Q4 2016 and held it in 3 quarters.
  • Neuberger Berman Canada's Integra LifeSciences position peaked at $1.12M in Q1 2017.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.